Skip to main content

Aditxt, Inc.

corporate_fare Company Profile

Aditxt, Inc.

Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed ADTX - Latest Insights

ADTX
Apr 23, 2026, 4:30 PM EDT
Filing Type: 424B3
Importance Score:
8
ADTX
Apr 14, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9
ADTX
Apr 10, 2026, 9:49 PM EDT
Filing Type: S-3
Importance Score:
9
ADTX
Apr 07, 2026, 4:02 PM EDT
Filing Type: 8-K/A
Importance Score:
9
ADTX
Apr 03, 2026, 4:37 PM EDT
Filing Type: DEF 14A
Importance Score:
9
ADTX
Apr 02, 2026, 9:23 AM EDT
Source: Wiseek News
Importance Score:
8
ADTX
Apr 02, 2026, 9:13 AM EDT
Filing Type: 8-K
Importance Score:
8
ADTX
Mar 31, 2026, 4:35 PM EDT
Filing Type: 10-K
Importance Score:
9
ADTX
Mar 30, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
ADTX
Mar 27, 2026, 5:02 PM EDT
Filing Type: 424B5
Importance Score:
9
ADTX
Mar 24, 2026, 5:21 PM EDT
Filing Type: PRE 14A
Importance Score:
8
ADTX
Mar 13, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
9
ADTX
Mar 13, 2026, 8:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
ADTX
Mar 05, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
8
ADTX
Mar 05, 2026, 8:30 AM EST
Source: Dow Jones Newswires
Importance Score:
8
ADTX
Feb 13, 2026, 5:03 PM EST
Filing Type: 8-K
Importance Score:
9
ADTX
Jan 30, 2026, 4:23 PM EST
Filing Type: 8-K
Importance Score:
9
ADTX
Jan 28, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8